Literature DB >> 26727937

[Anesthesia with liver failure].

Eva-Lotte Camboni-Schellenberg1, Barbara Sinner2.   

Abstract

Liver failure can be categorized into acute liver failure, chronic liver failure and acute decompensation of chronic liver failure, the so-called acute-on-chronic liver failure, the incidence of which has increased over the last few years. Liver failure leads to a variety of pathophysiological changes where the extent is dependent on the nature and duration of the liver disease. This includes restriction of synthesis and metabolism, such as coagulation defects. Especially chronic liver failure is associated with malfunction of extrahepatic organs, such as the cardiovascular system, the respiratory system and the kidneys. In addition to these pathophysiological alterations the Child-Turcotte-Pugh classification (CTP) and the model of end stage liver disease (MELD) are used for perioperative risk stratification.

Entities:  

Keywords:  Acute on chronic liver failure; Extrahepatic organ failure; Liver failure; Liver metabolism and -synthesis; Perioperative risk stratification

Mesh:

Substances:

Year:  2016        PMID: 26727937     DOI: 10.1007/s00101-015-0094-7

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  61 in total

1.  Sympathetic vesicovascular reflex induced by acute urinary retention evokes proinflammatory and proapoptotic injury in rat liver.

Authors:  Hong-Jeng Yu; Bor-Ru Lin; Hsuan-Su Lee; Chia-Tung Shun; Chih-Ching Yang; Ting-Yu Lai; Chiang-Ting Chien; Su-Ming Hsu
Journal:  Am J Physiol Renal Physiol       Date:  2004-12-21

2.  Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).

Authors:  Juan Cordoba; Meritxell Ventura-Cots; Macarena Simón-Talero; Àlex Amorós; Marco Pavesi; Hendrik Vilstrup; Paolo Angeli; Marco Domenicali; Pere Ginés; Mauro Bernardi; Vicente Arroyo
Journal:  J Hepatol       Date:  2013-10-12       Impact factor: 25.083

Review 3.  The coagulopathy of chronic liver disease.

Authors:  Armando Tripodi; Pier Mannuccio Mannucci
Journal:  N Engl J Med       Date:  2011-07-14       Impact factor: 91.245

4.  The 1995 Ciba-Geigy Award Lecture. Intrinsic regulation of hepatic blood flow.

Authors:  W W Lautt
Journal:  Can J Physiol Pharmacol       Date:  1996-03       Impact factor: 2.273

5.  Disturbances in hepatic blood flow during anesthesia and surgery.

Authors:  S I Gelman
Journal:  Arch Surg       Date:  1976-08

Review 6.  Portopulmonary hypertension.

Authors:  Michael J Krowka
Journal:  Semin Respir Crit Care Med       Date:  2012-03-23       Impact factor: 3.119

7.  Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis.

Authors:  C J Parker; J M Hunter
Journal:  Br J Anaesth       Date:  1989-02       Impact factor: 9.166

8.  Liver cirrhosis in patients undergoing laparotomy for trauma: effect on outcomes.

Authors:  Demetrios Demetriades; Constantinos Constantinou; Ali Salim; George Velmahos; Peter Rhee; Linda Chan
Journal:  J Am Coll Surg       Date:  2004-10       Impact factor: 6.113

9.  Sensitivity and specificity of bispectral index for classification of overt hepatic encephalopathy: a multicentre, observer blinded, validation study.

Authors:  A A Dahaba; H C Worm; S M Zhu; F P Bao; A Salah; S Zakaria; H Bornemann; V Stadlbauer; P H Rehak; H Metzler; R E Stauber
Journal:  Gut       Date:  2007-08-14       Impact factor: 23.059

10.  Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores.

Authors:  Amitabh Suman; David S Barnes; Nizar N Zein; Gavin N Levinthal; Jason T Connor; William D Carey
Journal:  Clin Gastroenterol Hepatol       Date:  2004-08       Impact factor: 11.382

View more
  1 in total

1.  [Anesthesiological aspects of liver transplantation].

Authors:  S Dehne; F Lund; J Larmann; K Schmidt; T Brenner; M A Weigand; R von Haken
Journal:  Anaesthesist       Date:  2019-06       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.